NCT00306540View on ClinicalTrials.gov

Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

August 31, 2008

Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG

Quetiapine Fumarate

oral flexible dose

DRUG

quetiapine fumarate placebo

oral 0 mg

Trial Locations (3)

Unknown

Research Site, Brisbane

Research Site, Adelaide

Research Site, Melbourne

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY